Hydroxychloroquine in SLE: old drug, new perspectives

Antimalarial agents have long been used in the treatment of autoimmune diseases, despite uncertainty regarding the exact mechanisms underlying their various effects. Growing evidence that these drugs offer protection from major infections could stimulate more research into these mechanisms, with pos...

Descripción completa

Detalles Bibliográficos
Autor principal: Dörner, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097534/
https://www.ncbi.nlm.nih.gov/pubmed/20046202
http://dx.doi.org/10.1038/nrrheum.2009.235
_version_ 1783511016554889216
author Dörner, Thomas
author_facet Dörner, Thomas
author_sort Dörner, Thomas
collection PubMed
description Antimalarial agents have long been used in the treatment of autoimmune diseases, despite uncertainty regarding the exact mechanisms underlying their various effects. Growing evidence that these drugs offer protection from major infections could stimulate more research into these mechanisms, with possible implications for therapy.
format Online
Article
Text
id pubmed-7097534
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70975342020-03-26 Hydroxychloroquine in SLE: old drug, new perspectives Dörner, Thomas Nat Rev Rheumatol Article Antimalarial agents have long been used in the treatment of autoimmune diseases, despite uncertainty regarding the exact mechanisms underlying their various effects. Growing evidence that these drugs offer protection from major infections could stimulate more research into these mechanisms, with possible implications for therapy. Nature Publishing Group UK 2010 /pmc/articles/PMC7097534/ /pubmed/20046202 http://dx.doi.org/10.1038/nrrheum.2009.235 Text en © Nature Publishing Group 2010 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Dörner, Thomas
Hydroxychloroquine in SLE: old drug, new perspectives
title Hydroxychloroquine in SLE: old drug, new perspectives
title_full Hydroxychloroquine in SLE: old drug, new perspectives
title_fullStr Hydroxychloroquine in SLE: old drug, new perspectives
title_full_unstemmed Hydroxychloroquine in SLE: old drug, new perspectives
title_short Hydroxychloroquine in SLE: old drug, new perspectives
title_sort hydroxychloroquine in sle: old drug, new perspectives
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097534/
https://www.ncbi.nlm.nih.gov/pubmed/20046202
http://dx.doi.org/10.1038/nrrheum.2009.235
work_keys_str_mv AT dornerthomas hydroxychloroquineinsleolddrugnewperspectives

Ejemplares similares